Metagenomi Therapeutics Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 12-2021 | |
| Sales | 11,337 | 8,657 | 0 | 0 |
| Gross Profit | 11,337 | 8,657 | N/A | N/A |
| Operating Expenses | 29,300 | 26,595 | 0 | 0 |
| Operating Income | -17,963 | -17,938 | N/A | N/A |
| Other Income | 6,853 | 4,002 | 0 | 0 |
| Pre-tax Income | -11,110 | -13,936 | 0 | 0 |
| Income Tax | 1,898 | 2,197 | N/A | N/A |
| Net Income Continuous | -13,008 | -16,133 | N/A | N/A |
| Net Income | $-13,008 | $-16,133 | $N/A | $N/A |
| EPS Basic Total Ops | -3.82 | -4.74 | N/A | N/A |
| EPS Basic Continuous Ops | -3.82 | -4.74 | N/A | N/A |
| EPS Diluted Total Ops | -3.82 | -4.74 | N/A | N/A |
| EPS Diluted Continuous Ops | -3.82 | -4.74 | N/A | N/A |
| EBITDA(a) | $-19,762 | $-19,330 | $N/A | $N/A |